Chat with us
Tigecycline 50 mg Injection is a next-generation glycylcycline antibiotic designed for the treatment of complicated and life-threatening bacterial infections, particularly those caused by multidrug-resistant (MDR) organisms. Tigecycline is a semi-synthetic derivative of minocycline that overcomes many common bacterial resistance mechanisms, including: Efflux pumps Ribosomal protection Tetracycline resistance It is specifically developed to treat serious infections caused by resistant pathogens, including MRSA, VRE, and ESBL-producing bacteria. Key Benefits of Tigecycline Injection ✔ Broad-spectrum antibacterial coverage ✔ Effective against multidrug-resistant pathogens ✔ Useful in polymicrobial infections ✔ Excellent tissue penetration ✔ Ideal for complicated infections ✔ Option when other antibiotics fail ✔ Convenient IV dosing schedule
